These data imply that the mutational repertoire and the epistatic interactions between different components of the PI3K pathway may be distinct in different tumor types, that genetic lesions in different components of the pathway may not have the same functional effects in different tumor types, and that a genetic determinant identified in one cancer type may not necessarily be applicable to another. The gene discussed is PIK3CG; the disease is cancer.